|
Publication |
|
CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma via M2 macrophage interactions: A bioinformatic analysis of the tumor microenvironment. Lou X, Zhao K, Xu J, Shuai L, Niu H, Cao Z, Wang J, Zhang Y. Front Immunol. 2022 Aug 22;13:950213. doi: 10.3389/fimmu.2022.950213. eCollection 2022.
|
|
MiR-7e-5p downregulation promotes transformation of low-grade follicular lymphoma to aggressive lymphoma by modulating an immunosuppressive stroma through the upregulation of FasL in M1 macrophages. Lou X, Fu J, Zhao X, Zhuansun X, Rong C, Sun M, Niu H, Wu L, Zhang Y, An L, Guo L, Wan S, Wang S. J Exp Clin Cancer Res. 2020 Nov 9;39(1):237. doi: 10.1186/s13046-020-01747-z.
|
|
microRNA‑196a‑3p inhibits cell proliferation and promotes cell apoptosis by targeting ADP ribosylation factor 4 in diffuse large B‑cell lymphoma. Fu J, Lou X, Wan S, Zhao X, Chen Z, Zhu M, Guo L, Wu D, Wang S. Oncol Rep. 2021 Feb;45(2):764-775. doi: 10.3892/or.2020.7901. Epub 2020 Dec 16.
|
|
Three-Dimensional Silk Fibroin/Chitosan Based Microscaffold for Anticancer Drug Screening. Niu H, Xiao J, Lou X, Guo L, Zhang Y, Yang R, Yang H, Wang S, Niu F. Front Bioeng Biotechnol. 2022 Mar 8;10:800830. doi: 10.3389/fbioe.2022.800830. eCollection 2022.
|
|
Expression and prognostic value of E2F3 transcription factor in non-small cell lung cancer. Wu L, et al. Oncol Lett. 2021.
|
|
| | Last update Publications 21.10.2024 |
|